Contradictory results again show a mixed treatment effect with some studies favoring combined therapy, while others show no additional benefit compared to systemic therapy alone [98, 118,119,120,121,122]
This is common with weight loss peptides and other GLP-1 medications
Any potential mood benefits should be considered an additional effect rather than a primary therapeutic goal
Instances of contamination and improper dosing are not uncommon, and the consequences can be severe
Subcutaneous administration is required (daily in two doses for exenatide, one for liraglutide and lixisenatide, and weekly for exenatide-LAR [long-acting release] and dulaglutide), as well as training regarding the potential adverse effects
It can also slow how quickly your stomach empties itself after eating (affecting how full you feel after a meal)